Juan Verdaguer T, MD
(Santiago, Chile) |
Current Treatment for Diabetic Macular Edema (DME)
Volume 34, Number # 6, 2006 Series
Juan Verdaguer T, MD
(Santiago, Chile) |
1. Klein R, Moss SE, Klein Bek et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XI: The incidence of macular edema. Ophthalmology 1989; 96: 1501-1510.
2. Verdaguer T.J, Vicencio C, Zúñiga C, Molina E. Tamisaje de retinopatía diabética en Latinoamérica. Resultados Arch. Chil. Oftal. 2001; 58;39-43.
3. Do, DV, Shah SM, Sung J, Haller J, Nguyen AD. Persistent diabetic macular edema is associated with elevated hemoglobin A1C. Am. J. Ophthalmol. 2006; 139: 620-623.
4. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Eng. J. Med. 1999; 329; 977-986.
5. Chew EY, Klein ML, Ferris FL III et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. ETDRS Report Number 22, Arch. Ophthalmol. 1996; 114: 1079-1084.
6. UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complication in type 2 diabetes. UK PDS 38, Br. Med. J .1998; 317: 703-713.
7. Early Treatment Diabetic Retinopathy Study Research Group: Photocoagulation for diabetic macular edema. ETDRS Report Number 1. Arch. Ophthalmol. 1985; 103: 1796-1806.
8. Gillies MC, Sutter FK, Simpson JM et al. Intravitreal triamcinolone for refractive macular edema. Two years results of a double masked, placebo controlled, randomized clinical trial Ophtalmology 2006.
9. Kang SW, Ja H-S, Cho HY, Kin JL. Macular grid photocoagulation after intravitreal triamcinolone acetonide for diffuse diabetic macular edema. Arch. Ophthalmol. 2006; 124: 653-658.
|
